Bridge & Friends: MedDiet with Social Networks for obesity in older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial assigns 268 adults aged 50-79 with obesity to either MedDiet-WL (Mediterranean diet with weight loss) or MedDiet-SN (Mediterranean diet with a social-network component) for 6 months. Researchers will compare changes in weight, BMI, body fat, diet quality, and physical activity between groups, and will see if benefits persist at 12 months. The study also examines how participants share weight-management information within their networks and whether network members experience similar changes. The social-network arm aims to amplify information dissemination and behavior change beyond the individual participant. The study takes place in Chicago, led by the University of Illinois Chicago.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 50-79 yrs old,
* BMI 30-50
* Willing to participate in all procedures
* Understand English
* Willing to make changes to diet and lifestyle
* Have access to a phone
* Plan to reside in the Chicago area for the next 12 months

Exclusion Criteria:

* Severe ischemic heart disease
* Severe pulmonary disease
* Bariatric surgery
* Cancer treatment within the past 12 months
* Current adherence to MedDiet based on dietary screening

Where it's running

• University of Illinois Chicago
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Lara Blumstein, MA
• Email: lbb@uic.edu
• Phone: +1 77304903311

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How incretin treatments affect muscle mass and function in people with overweight or obesity

  This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

  Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

• Dose find for remimazolam plus alfentanil for gastroscopy in obese adults

  This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07925684

• Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults

  This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.

  Recruiting Yuzuncu Yil University · Van · NCT07901777

• Gut barrier and inflammation after fast-food overfeeding in adults

  This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.

  Recruiting University Hospital, Gentofte, Copenhagen · Hellerup · NCT07893743

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• GLP-1 weight‑loss medicine: finding who will benefit most

  This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.

  Recruiting Phase 4 Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07870538

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.